Schedule 13G ownership disclosure
N/A
Security class unavailable · CUSIP: 09627Y109
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 6,114,970
- Percent of class
- 10.0600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-002863
- Form type
- SC 13G
- Filer
- Blueprint Medicines Corp
- CIK
- CIK 1597264
- Filed
- Jan 10, 2024
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership